| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5396826ac8c36d31e3eb53c9ef088a68 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 |
| filingDate |
2016-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44992e6a48b8ab364766eed450b00351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f21d8c43cc1375d50a89137ed66a6439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c22a57c9165d6f6216c44d948e90e15a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08c59d45149880ceac40e03123e30ae3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42a3c9b83978c6cd6555cad26ab687d3 |
| publicationDate |
2018-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180001112-A |
| titleOfInvention |
Layer by layer assembly of albumin conjugate and pharmaceutical composition using the same |
| abstract |
The present invention relates to a lamellar self assembly of albumin conjugate and a pharmaceutical composition using the same, wherein the lamellar self assembly of the albumin conjugate is surrounded by a polyamino acid around the albumin conjugate using layer by layer (LbL) to prevent decomposition of the conjugate, as well as significantly improve the colloidal stability and dynamic performance about the blood, it is possible to sustain the drug release can be useful as an anticancer agent capable of improving the disadvantages of Havre Leshan ®. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3937981-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111635539-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111635539-B |
| priorityDate |
2016-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |